.: U.S. Senate Committee on Environment and Public Works

Full Committee hearing entitled, “Oversight on EPA Toxic Chemical Policies.”

Tuesday, April 29, 2008

10:00 AM EDT

EPW Hearing Room - 406 Dirksen

Majority Statements

Barbara Boxer

Minority Statements

James M. Inhofe

Witnesses

Opening Remarks

Panel 1

The Honorable James B. Gulliford
Assistant Administrator for Pesticides, Prevention, and Toxic Substances
United States Environmental Protection Agency

Panel 2

Linda Giudice MD, PhD
Chair, Obstetrics, Gynecology & Reproductive Sciences Department
University of California, San Francisco

Annette Gellert
Co-Founder and Chair
WELL Network

V.M. DeLisi
Fanwood Chemical, Inc.
On the behalf of the Synthetic Organic Chemicals Manufacturers Association

Laura Plunkett PhD
Integrative Biostrategies, LLC

Lynn R. Goldman, MD, MPH MD, MPH
Chair, Interdepartmental Program in Applied Public Health, Environmental Health Sciences, Occupational and Environmental Health
Johns Hopkins University

4.28.2008 Center for Progressive Reform IRIS letter to EPA
CPRLetter.pdf | 173.2 KBs
4.28.2009 Grassroots IRIS letter to EPA
GrassRootsIRISletter.pdf | 78.0 KBs
4.29.2008 NRDC and ED IRIS letter to EPA
NRDCandEDletter.pdf | 114.5 KBs
IRIS Process Charts
IRISProcessCharts.pdf | 99.9 KBs
GAO Report: Chemical Assessments
GAOreport.pdf | 1.3 MBs

Low Productivity and New Interagency Review Process Limit the Usefullness and Credibility of EPA's Integrated Risk Information System

Oversight on EPA Toxic Chemical Policies: April 29, 2008

Majority Office
410 Dirksen Senate Office Bldg.Washington, DC 20510-6175
phone: 202-224-8832

Minority Office
456 Dirksen Senate Office Bldg.Washington, DC 20510-6175
phone: 202-224-6176

Low Productivity and New Interagency Review Process Limit the Usefullness and Credibility of EPA's Integrated Risk Information System